Delivery Order SPE2DP25D0001-SPE2DP25F5841

Award Date 4/15/25
Potential Completion Date 4/18/25
Potential Value $3K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Swiftwater, PA 18370, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer specializing in vaccines and medical supplies. The contract, valued at $1,336,273.60, is for the delivery of influenza virus vaccines. The contract has an ultimate completion date of September 26, 2025 and does not have a set-aside designation. Sanofi Pasteur Inc. is a major global supplier of vaccines and medical...
This is a federal contract award to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer of vaccines and medical supplies, for the provision of influenza virus vaccines. The contract has a ceiling value of $983,915.20 and is a firm fixed price delivery order, with an ultimate completion date of September 26, 2025. The contract is awarded by the Defense Logistics Agency, a component of the Department of Defense, and is not set aside for any specific business category....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $12,907.62, is for the supply of influenza virus vaccines. The contract has an ultimate completion date of March 31, 2025. Sanofi Pasteur Inc. is a major global supplier of vaccines and medical countermeasures to various U.S. federal government agencies, including the Centers for Disease Control and...
This is a $6,025,705.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of influenza virus vaccines. The contract has an ultimate completion date of September 26, 2025 and does not utilize any set-aside designations. Sanofi Pasteur Inc. is a major global supplier of vaccines and medical countermeasures to various U.S. federal government agencies,...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency to Sanofi Pasteur Inc., a foreign-owned for-profit manufacturer, for the provision of influenza virus vaccines. The contract has a ceiling value of $2,794,325.82 and a period of performance through November 15, 2016. Sanofi Pasteur Inc. has been awarded numerous indefinite delivery vehicles (IDVs) from various federal agencies, including a $5.87 billion IDIQ from the HHS Office of the Assistant Secretary for...
This is a delivery order contract awarded by the Medical Supply Chain, a component of the Defense Department, to Sanofi Pasteur Inc., a foreign-owned pharmaceutical manufacturer of vaccines and medical supplies. The contract is for the delivery of influenza virus vaccines, with a ceiling value of $804,900.80 and a period of performance ending on September 26, 2025. The contract is a firm fixed price vehicle and does not utilize any set-aside designations. Sanofi Pasteur Inc. is a major...
This is a federal contract award to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer, by the Defense Logistics Agency (DLA) for the delivery of influenza virus vaccines. The contract has a ceiling value of $23,926.32 and an ultimate completion date of April 18, 2025. The contract is a delivery order, with a firm fixed price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) vehicle held by Sanofi Pasteur Inc. with various federal agencies,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer specializing in vaccines and medical supplies. The contract, valued at $3,893,798.40, is for the delivery of influenza virus vaccines. The contract does not have a set-aside designation. Sanofi Pasteur Inc. is a major global supplier of vaccines and medical countermeasures to various U.S. federal government agencies,...
This is a $2,682,187.20 firm fixed price delivery order awarded to Sanofi Pasteur Inc. by the Defense Logistics Agency (DLA) to provide Influenza Virus Vaccines. The award has an ultimate completion date of October 11, 2024 and is not associated with a set-aside designation. Sanofi Pasteur Inc. is a foreign-owned, for-profit manufacturer of pharmaceutical goods that holds several indefinite delivery vehicles (IDVs) with the Department of Health and Human Services, Centers for Disease Control and...
This is a federal contract award to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the production of influenza virus vaccines. The contract, awarded by the Medical Supply Chain division of the Defense agency, is a delivery order with a firm fixed price of $3,150,107.50 and an ultimate completion date of October 13, 2023. The contract does not have a set-aside designation. Sanofi Pasteur Inc. is a major supplier of vaccines and medical countermeasures to various...
  • SPE2DP25D0001
    Indefinite Delivery Contract
  • SPE2DP25D0001-SPE2DP25F5841
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the provision of influenza virus vaccines. The contract has a ceiling value of $2,990.79 and a period of performance ending on April 18, 2025. It is a firm fixed-price contract with no set-aside designation. Sanofi Pasteur Inc. is a major global supplier of vaccines and medical countermeasures to various U.S. federal agencies, including the Centers for Disease Control and Prevention (CDC), Department of Veterans Affairs, and Department of Health and Human Services. The company holds multiple significant Indefinite Delivery Contracts (IDVs) with these agencies for a broad range of vaccine procurement, supporting critical public health initiatives across federal, state, and tribal healthcare systems.

Generated 7/17/25, 5:52 PM